Dr. Greene discusses the morphology of lung infections in the immunocompromised host. Infections covered include invasive aspergillosis, mucormycosis, nocardiosis, legionella, and nontuberculous mycobacterial infections.
Dr. Morano discusses the initial work-up and evaluation of the HIV positive patient. The second of two parts.
Dr. Morano discusses the initial work-up and evaluation of the HIV positive patient. The first of two parts.
Dr Antoneh Addisu describes the history and taxonomy of Bartonella species, including basic microbiology of this important organism. He differentiates between the major syndromes caused by Bartonella organisms and associates them with specific species. Diagnostic considerations are also discussed. A more obscure manifestation of Bartonella infection is culture negative endocarditis, which is also reviewed. Lastly, the speaker discusses therapy for Bartonella infections.
Dr. Maria L Alcaide, Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine, presents an update on sexually transmitted diseases with a emphasis on the state of Florida. She focuses on recent epidemiology, specific syndromes including syphilis, urethritis and the genital ulcer diseases, as well as HIV-STD interactions.
Dr. Rod Quilitz, ID clinical pharmacist and Moffitt Cancer Center and Research Institute, discusses the Moffitt approach to the identification, assessment, and management of invasive fungal infections in the immunocompromised host.
Dr. Cheung reviews important concepts about the current flu season with regard to current influenza epidemiology, prevention, influenza vaccination, prophylaxis, and treatment.
Dr. Baluch covers the necessary steps to establish and conduct a successful antibiotic stewardship program in an oncology hospital. She covers population specific factors in the immunocompromised population, laboratory diagnostic resources, core elements, recruiting necessary personnel for the ASP team, and how to be compliant with accreditation standards.
Dr. Yanina Pasikhova discusses the use of trimethoprim/sulfamethoxasole in the treatment of Nocardiosis in hematopoietic stem cell transplant patients. She utilizes a case-based format to highlight the typical risk factors, presentation, and management of nocardia disease in at-risk patients.
Dr. Oehler discusses the epidemiology, assessment, clinical diagnosis, and therapeutic and supportive management of nontuberculous mycobacteria infections. The importance of bronchial hygiene and secretion clearance mechanisms is also discussed.
